EGFR mRNA-Engineered Mesenchymal Stem Cells (MSCs) Demonstrate Radioresistance to Moderate Dose of Simulated Cosmic Radiation
Preprint
- 3 September 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Galactic cosmic ray (GCR) radiation is a major barrier to human space exploration beyond Earth’s magnetic field protection. Mesenchymal stem cells (MSCs) are found in all organs, and they play a critical role in repair and regeneration of tissue. We specifically use engineered bone marrow-derived MSCs as a model to evaluate the effect of radiation exposure during deep space travel and long-duration spaceflight. Epidermal growth factor receptor (EGFR) expression by certain types of cancers has been shown to induce radioresistance. In this study, we tested the feasibility of engineering MSCs to overexpress EGFR (eMSC-EGFR) and evaluated their capacity to tolerate and recover from exposure to x-ray exposure (1 – 20 Gy). Quantitative real-time PCR (qRT-PCR) and immunoblotting results have shown that EGFR was efficiently transfected into MSCs and EGFR protein was produced. eMSC-EGFR maintained characteristics of human MSCs as outlined by the International Society for Cell & Gene Therapy. Then, both eMSC-EGFR and naïve MSCs were exposed to various dose rates of x-ray irradiation to assess the potential radioprotective role of EGFR overexpression in MSCs. Analysis included post-irradiation evaluation of morphology, cell proliferation, tumorigenic potential, and DNA damage. eMSC-EGFR showed signs of radioresistance compared to naïve MSCs when assessing relative proliferation one week following exposure at doses of 1–8 Gy and significantly lower DNA damage content 24 hours after exposure to 4 Gy. We establish for the first time the feasibility of efficiently generating EGFR overexpressing MSCs as a model for enhancing the human body to tolerate and recover from moderate dose radiation injury in long-term manned space travel.Keywords
All Related Versions
- Version 1, 2025-09-03, Preprints
- Published version: Cells, 14 (21), 1719.
This publication has 70 references indexed in Scilit:
- MSCs in Space: Mesenchymal Stromal Cell Therapeutics as Enabling Technology for Long-Distance Manned Space TravelCurrent Stem Cell Reports, 2022
- Development and evaluation of IL‐6 overexpressing mesenchymal stem cells (MSCs)Journal of Tissue Engineering and Regenerative Medicine, 2021
- Radiation‐induced tissue damage and responseThe Journal of Pathology, 2020
- Mechanisms underlying the protective effects of mesenchymal stem cell-based therapyCellular and Molecular Life Sciences, 2020
- The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancerCancer and Metastasis Reviews, 2016
- Bone Marrow Mesenchymal Stem Cells: Biological Properties and Their Role in Hematopoiesis and Hematopoietic Stem Cell TransplantationStem Cell Reviews and Reports, 2011
- Squamous Cell Carcinoma of the Esophagus: Evaluation of the Status of Epidermal Growth Factor Receptors (EGFR and HER-2) by Immunohistochemistry and in Situ HybridizationBulletin of Experimental Biology and Medicine, 2010
- EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagusInternational Journal of Cancer, 2005
- Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinomaJournal of Cancer Research and Clinical Oncology, 2004
- The dose-rate effect revisited: Radiobiological considerations of importance in radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1991